CPC A61K 39/0011 (2013.01) [C07K 7/06 (2013.01); C07K 7/08 (2013.01); C07K 14/4748 (2013.01); C07K 14/705 (2013.01); C07K 14/70503 (2013.01); C07K 16/2803 (2013.01); C07K 16/2833 (2013.01); C07K 16/30 (2013.01); C12N 5/0638 (2013.01); C12N 15/115 (2013.01); C12Q 1/6886 (2013.01); A61K 2039/5158 (2013.01); A61K 2039/572 (2013.01); A61K 2039/80 (2018.08); C07K 2317/32 (2013.01); C07K 2319/40 (2013.01); C12N 2310/16 (2013.01); C12Q 2600/156 (2013.01); C12Q 2600/158 (2013.01)] | 20 Claims |
1. A method of treating a patient who has hepatocellular cancer, comprising administering to said patient a population of activated T cells that kill cancer cells that present on the surface a peptide consisting of the amino acid sequence of KVLEHVVRV (SEQ ID NO: 1) wherein the activated T cells bind the peptide in a complex with an MHC class I molecule on the surface of the cancer cells.
|